Skip to main content
SpringerLink
Log in

Dermatomyositis

  • Chapter
Autoimmune Diseases of the Skin

  • 1326 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abernethy ML, Arterberry JF, Callen JP (1996) Low-dose methotrexate as an adjunctive therapy with surgery for ectropion complicating dermatomyositis. Dermatology 192(2): 153–155

    PubMed  Google Scholar 

  • Al-Mayouf SM, Laxer RM, Schneider R, Silverman ED, Feldman BM (2000a) Intravenous immunoglobulin therapy for juvenile dermatomyositis: efficacy and safety. J Rheumatol 27: 2498–2503

    PubMed  Google Scholar 

  • Al-Mayouf S, Al-Mazyed A, Bahabri S (2000b) Efficacy of early treatment of severe juvenile dermatomyositis with intravenous methylprednisolone and methotrexate. Clin Rheumatol 19: 138–141

    Article  PubMed  Google Scholar 

  • Airio A, Pukkala E, Isomäki (1995) Elevated cancer incidence in patients with dermatomyositis: A population based study. J Rheumatol 22: 1300–1303

    PubMed  Google Scholar 

  • Bohan A, Peter JB (1975) Polymyositis and dermatomyositis. N Engl J Med 292: 344–347 and 403–407 (two part article)

    PubMed  Google Scholar 

  • Bohan A, Peter JB, Bowman RL, Pearson CM (1977) A computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine 56: 255–286

    PubMed  Google Scholar 

  • Callen AM, Pachman LM, Hayford J, Chung A, Ramsey-Goldman R (1994) Intermittent high dose intravenous methylprednisolone (IV pulse) prevents calcinosis and shortens disease course in juvenile dermatomyositis (JDMS). Arth Rheum 37: R10A

    Google Scholar 

  • Callen JP (1982) The value of malignancy evaluation in patients with dermatomyositis. J Am Acad Dermatol 6: 253–259

    PubMed  Google Scholar 

  • Callen JP (1993) Photodermatitis in a 6-year-old child. Arhthritis Rheum 36: 1483–1485

    Google Scholar 

  • Callen JP (1999) Photosensitivity in collagen vascular diseases. Semin Cutan Med Surg 18(4): 293–296

    PubMed  Google Scholar 

  • Callen JP (2000) Dermatomyositis. Lancet 355: 53–57

    PubMed  Google Scholar 

  • Callen JP (2000) When and how should the patient with dermatomyositis or amyopathic dermatomyositis be assessed for possible cancer? Arch Dermatol 138: 969–971

    Google Scholar 

  • Cheong W-K, Hughes GRV, Norris PG, Hawk JLM (1994) Cutaneous photosensitivity in dermatomyositis. Brit J Dermatol 131: 205–208

    Google Scholar 

  • Cherin P, Pelletier S, Teixeira A, Laforet P, Genereau T, Simon A, Maisonobe T, Eymard B, Herson S (2002): Results and long-term followup of intravenous immunoglobulin infusions in chronic, refractory polymyositis. Arthritis Rheum 46: 467–74.

    Article  PubMed  Google Scholar 

  • Chow WH, Gridley G, Mellemkjaer L, McLaughlin JK, Olsen JH, Fraumeni JF Jr (1995) Cancer risk following polymyositis and dermatomyositis: A nationwide cohort study in Denmark. Cancer Causes and Control 5: 9–13

    Article  Google Scholar 

  • Cosnes A, Amaudric F, Gherardi R, Verroust J, Wechsler J, Revuz J, Roujeau JC (1995) Dermatomyositis without muscle weakness. Long-term follow-up of 12 patients without systemic corticosteroids. Arch Dermatol 131: 1381–1385

    Article  PubMed  Google Scholar 

  • Dacey MJ, Callen JP (2003) Hydroxyurea-induced dermatomyositis-like eruption. J Am Acad Dermatol 48: 439–441.

    Article  PubMed  Google Scholar 

  • Dalakas MC, Illa I, Dambrosia JM, Soueidan SA, Stein DP, Otero C, Dinsmore ST, McCrosky S (1993) A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med 329: 1993–2000

    Article  PubMed  Google Scholar 

  • Dalakas MC (1998) Molecular immunology and genetics of inflammatory muscle diseases. Arch Neurol 54: 1509–1512

    Article  Google Scholar 

  • Daoud MS, Gibson LE, Pittelkow MR (1997) Hydroxyurea dermopathy. A unique lichenoid eruption complicating long-term therapy with hydroxyurea. J Am Acad Dermatol 36: 178–182

    PubMed  Google Scholar 

  • Douglas WW, Tazezlaer HD, Hartman TE, Hartman RP, Decker PA, Schroeder DR, Ryu JH (2001) Polymyositis-dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med. 164: 1182–5.

    PubMed  Google Scholar 

  • Dourmishev AL, Dourshimev LA (1999) Dermatomyositis and drugs. Adv Exp Med Biol 445: 187–191

    Google Scholar 

  • E1-Azhary RA, Pakzad SY (2002) Amyopathic dermatomyositis: retrospective review of 37 cases. J Am Acad Dermatol 46: 560–565

    Article  PubMed  Google Scholar 

  • Euwer RL, Sontheimer RD (1991) Amyopathic DM (DM sine myositis). J Am Acad Dermatol 24: 959–966

    PubMed  Google Scholar 

  • Garcia J (2000) MRI in inflammatory myopathies. Skeletal Radiol 29: 425–438

    Google Scholar 

  • Gelber AC, Nousari HC, Wigley FM (2000) Mycophenolate mofetil in the treatment of severe skin manifestations of dermatomyositis: a series of 4 cases. J Rheumatol 27: 1542–1545

    PubMed  Google Scholar 

  • Ghali FE, Stein LD, Fine J-D, Burkes EJ, McCauliffe DP (1999) Gingival telangiectases. An underappreciated physical sign of juvenile dermatomyositis. Arch Dermatol 135: 1370–1374

    Article  PubMed  Google Scholar 

  • Gonzalez-Lopez L, Gamez-Nava JI, Sanchez L, Rosas E, Suarez-Almazor M, Cardona-Munoz C, Ramos-Remus C (1996) Cardiac manifestations in dermato-polymyositis. Clin Exp Rheumatol 14: 373–379

    PubMed  Google Scholar 

  • Hengstman G, van den Hoogen F, van Engelen B, Barrera P, Netea M, van den Putte L (2000) Anti-TNF-blockade with infliximab (remicade) in polymyositis and dermatomyositis. Arthritis Rheum 43: S193A

    Google Scholar 

  • Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A, Evan SR, Felson DT (2001) Frequency of specific cancer types in dermatomyositis and polymyositis: A population-based study. Lancet 357: 96–100

    Article  PubMed  Google Scholar 

  • Huemer C, Kitson H, Malleson PN, Sanderson S, Huemer M, Cabral DA, Chanoine J-P, Petty RE (2001) Lipodystrophy in patients with juvenile dermatomyositis — evaluation of clinical and metabolic abnormalities. J Rheumatol 28: 610–615.

    PubMed  Google Scholar 

  • Hollar CB, Jorizzo JL (2004) Topical tacrolimus 0.1% ointment for refractory skin disease in dermatomyositis: a pilot study. J Dermatolog Treat 15: 35–9.

    Article  PubMed  Google Scholar 

  • Huber AM, Lang B, LeBlanc CM, Birdi N, Bolaria RK, Malleson P (2000) Medium-and long-tern functional outcomes in a multicenter cohort of children with juvenile dermatomyositis. Arthritis Rheum 43: 541–549

    PubMed  Google Scholar 

  • Kasteler JS, Callen JP (1994) Scalp involvement in dermatomyositis. Often overlooked or misdiagnosed. JAMA 272: 1939–1941

    Article  PubMed  Google Scholar 

  • Kasteler JS, Callen JP (1997) Low-dose methotrexate administered weekly in an effective corticosteroid-sparing agent for the treatment of the cutaneous manifestations of dermatomyositis. J Am Acad Dermatol 36: 67–71

    PubMed  Google Scholar 

  • Kaufmann R, Greiner D, Schmidt P, Wolter M (1998) Dermatomyositis presenting as plaque-like mucinosis. Brit J Dermatol 138: 889–892

    Article  Google Scholar 

  • Kuru S, Inukai A, Liang Y, Doyu M, Takano A, Sobue G (2000) Tumor necrosis factor-a expression in muscles of polymyositis and dermatomyositis. Acta Neuropathol 99: 585–588

    Article  PubMed  Google Scholar 

  • Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH, Miller FW (1991) A new approach to the classification of idiopathic inflammatory myopathy: Myositis-specific autoantibodies define useful homogeneous patient groups. Medicine 70(6): 360–374

    PubMed  Google Scholar 

  • Lundberg IE, Nyberg P (1998) New developments in the role of cytokines and chemokines in inflammatory myopathies. Curr Opinion in Rheumatol 10: 521–529

    Google Scholar 

  • Marie I, Hatron P-Y, Hachulla E, Wallaert B, Michon-Pasturel U, Devulder B (1998) Pulmonary involvement in polymyositis and in dermatomyositis. J Rheumatol 25: 1336–1343

    PubMed  Google Scholar 

  • Marie I, Hatron PY, Levesque H, Hachulla E, Hellot MF, Michon-Pasturel U, Courtois H, Devulder B (1999) Influence of age on characteristics of polymyositis and dermatomyositis in adults. Medicine 78: 139–147

    Article  PubMed  Google Scholar 

  • Marie I, Joly P, Levesque H, Heron F, Courville P, Cailleux N, Courtois H (2000) Pseudo-dermatomyositis as a complication of hydroxyurea therapy. Clin Exp Rheumatol 18: 536–537

    PubMed  Google Scholar 

  • McCollough ML, Cockerell CJ (1998) Vesiculo-Bullous Dermatomyositis. Am J Dermatopathol 20: 170–174

    Article  PubMed  Google Scholar 

  • Miller FW, Leitman SF, Cronin ME, Hicks JE, Leff RL, Wesley R, Fraser DD, Dalakas M, Plotz PH (1992) Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis. N Engl J Med 326: 1380–1384

    PubMed  Google Scholar 

  • Nousari HC, Ha VT, Laman SD, Provost TT, Tausk FA (1999) ‘Centripetal Flagellate Erythema’: A Cutaneous Manifestation Associated with Dermatomyositis. J Rheumatol 26: 692–695

    PubMed  Google Scholar 

  • Nyberg P, Wikman A-L, Nennesmo I, Lundberg I (2000) Increased expression of Interleukin 1a and MHC class I in muscle tissue of patients with chronic, inactive polymyositis and dermatomyositis. J Rheumatol 27: 940–948

    PubMed  Google Scholar 

  • Oliveri MB, Palermo R, Mautalen C, Hübscher O (1996) Regression of calcinosis during Diltiazem treatment of juvenile dermatomyositis. J Rheumatol 23: 2152–2155

    PubMed  Google Scholar 

  • Pachman LM (1995) An update on juvenile dermatomyositis. Curr Opin Rheumatol 7: 437–441

    PubMed  Google Scholar 

  • Pachman LM, Liotta-Davis MR, Hong DK, Kinsella TR, Mendez EP, Kinder JM, Chen EH (2000) TNFa-308A allele in juvenile dermatomyositis. Arthritis Rheum 43: 2368–2377

    PubMed  Google Scholar 

  • Pautas E, Cherin P, Piette J-C, Pelletier S, Wechsler B, Cabane J, Herson S (2000) Features of polymyositis and dermatomyositis in the elderly: A case-control study. Clin Exp Rheumatol 18: 241–244

    PubMed  Google Scholar 

  • Pelle MT, Callen JP (2002) Adverse cutaneous reactions to hydroxychloroquine are more common in patients with dermatomyositis than in patients with cutaneous lupus erythematosus. Arch Dermatol 138: 1231–1233

    Article  PubMed  Google Scholar 

  • Peng J-C, Sheem T-S, Hsu M-M (1995) Nasopharyngeal carcinoma with dermatomyositis. Analysis of 12 cases. Arch Otolaryngol Head Neck Surg 121: 1298–1301

    PubMed  Google Scholar 

  • Plotz PH, Rider LG, Targoff IN, Raben N, O’Hanlon TP, Miller FW (1995) Myositis: Immunologic Contributions to Understanding Cause, Pathogenesis, and Therapy. Ann Intern Med 122: 715–724

    PubMed  Google Scholar 

  • Requena L, Grilli R, Soriano L, Escalonilla P, Farina C, Martin L (1997) Dermatomyositis with a pityriasis rubra pilaris-like eruption: a little-known distinctive cutaneous manifestation of dermatomyositis. Brit J Dermatol 136: 768–771

    Google Scholar 

  • Rockerbie NR, Woo TY, Callen JP, Giustina T (1989) Cutaneous changes of dermatomyositis precede muscle weakness. J Am Acad Dermatol 20: 629–632

    PubMed  Google Scholar 

  • Saadeh CK (2000) Etanercept is effective in the treatment of polymyositis/dermatomyositis which is refractory to conventional therapy including steroids and other disease modifying agents. Arhtritis Rheum 43: S193A

    Google Scholar 

  • Sawhney S, Sidoti G, Woo P, Murray KJ (2000) Clinical characteristics and outcome of idiopathic inflammatory myositis (IIM) in childhood: A 2 year follow up. Arthritis Rheum 43: A

    Google Scholar 

  • Sayers ME, Chou SM, Calabrese LH (1992) Inclusion body myositis: Analysis of 32 cases. J Rheumatol 19: 1385–1389

    PubMed  Google Scholar 

  • Shannon PL, Ford MJ (1999) Angiokeratomas in juvenile dermatomyositis. Pediatr Dermatol 16: 448–451

    Article  PubMed  Google Scholar 

  • Shimizu T, Tomita Y, Son K, Nishinarita S, Sawada S, Horie T (2000) Elevation of serum soluble tumor necrosis factor receptors in patients with polymyositis and dermatomyositis. Clin Rheumatol 19: 352–359

    Article  PubMed  Google Scholar 

  • Sontheimer RD (2002) Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J Am Acad Dermatol 46: 626–636.

    Article  PubMed  Google Scholar 

  • Spiera R, Kagen L (1998) Extramuscular manifestations in idiopathic inflammatory myopathies. Curr Opinion in Rheumatol 10: 556–561

    Google Scholar 

  • Siguregeirsson B, Lindelöf B, Edhag O, Allander E (1992) Risk of cancer in patients with dermatomyositis or polymyositis. N Engl J Med 325: 363–367

    Google Scholar 

  • Sinoway PA, Callen JP (1993) Chlorambucil: An Effective Corticosteroid-Sparing Agent for Patients with Recalcitrant Dermatomyositis. Arthritis Rheum 36: 319–324

    PubMed  Google Scholar 

  • Sugugiura T, Kawaguchi Y, Harigai M, Takagi K, Ohta S, Fukasawa C, Hara M, Kamatani N (2000) Increased CD40 expression on muscle cells of polymyositis and dermatomyositis: Role of CD40-CD40 ligand interaction in IL-6, IL-8, IL-5, and monocyte chemoattractant protein-1 production. J Immunol 164: 6593–6000

    PubMed  Google Scholar 

  • Stonecipher MR, Jorizzo JL, White WL, Walker FO, Prichard E (1993) Cutaneous changes of dermatomyositis in patients with normal muscle enzymes: DM sine myositis? J Am Acad Dermatol 28: 951–956

    PubMed  Google Scholar 

  • Targoff IN (1991) Dermatomyositis and polymyositis. Curr Prob Dermatol 3: 131–180

    Article  Google Scholar 

  • Targoff IN, Trieu EP, Sontheimer RD (2000) Autoantibodies to 155 kd and Se antigens in patients with clinically-amyopathic dermatomyositis. Arthritis Rheum 43: S194A

    Google Scholar 

  • Vencovsky J, Jarosova K, Machacek S, Studynkova J, Kafvova J, Bartunkova J, Nemcova D, Charvat F (2000) Cyclosporine A versus methotrexate in the treatment of polymyositis and dermatomyositis. Scand J Rheumatol 29: 95–102

    Article  PubMed  Google Scholar 

  • Villalba L, Adams EM (1996) Update on therapy for refractory dermatomyositis and polymyositis. Curr Opinion Rheumatol 8: 544–551

    Google Scholar 

  • Villalba L, Hicks JE, Adams EM, Sherman JB, Gourley MF, Leff RL, Thornton BC, Burgess SH, Plotz PH, Miller FW (1998) Treatment of refractory myositis. A randomized crossover study of two new cytotoxic regimens. Arthritis Rheum 41(3): 392–399

    PubMed  Google Scholar 

  • Wanchu A, Khullar M, Sud A, Bambery P (1999) Nitric oxide production is increased in patient with inflammatory myositis. Nitric Oxide 3: 454–458

    Article  PubMed  Google Scholar 

  • Whitmore SE, Rosenshein NB, Provost TT (1994) Ovarian cancer in patients with dermatomyositis. Medicine 73: 153–160

    PubMed  Google Scholar 

  • Woo TY, Callen JP, Voorhees JJ, Bickers DR, Hanno R, Hawkins C (1984) Cutaneous lesions of dermatomyositis are improved by hydroxychloroquine. J Am Acad Dermatol 10: 592–600

    PubMed  Google Scholar 

  • Woo TR, Rasmussen J, Callen JP (1985) Recurrent photosensitive dermatitis preceding juvenile dermatomyositis. Pediatr Dermatol 2: 207–212

    PubMed  Google Scholar 

  • Wortmann RL (2001) Idiopathic Inflammatory diseases of muscle. In Treatment of the Rheumatic Diseases. Weisman ML, Weinblatt ME, Louie JS (eds) W. B. Saunders Co. pp 390–402

    Google Scholar 

  • Zieglschmid-Adams ME, Pandya AG, Cohen SB, Sontheimer RD (1995) Treatment of dermatomyositis with methotrexate. J Am Acad Dermatol 32: 754–757

    Article  PubMed  Google Scholar 

  • Zuber M, John S, Pfreundschuh M, Gause A (1996) A young woman with a photosensitive pruritic rash on her face and upper trunk. Arthritis Rheum 39: 1419–1422

    PubMed  Google Scholar 

Download references

Authors
  1. Jeffrey P. Callen
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Dermatology and Allergology, Philipps University, Marburg, Germany

    Michael Hertl MD

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Wien

About this chapter

Cite this chapter

Callen, J.P. (2005). Dermatomyositis. In: Hertl, M. (eds) Autoimmune Diseases of the Skin. Springer, Vienna. https://doi.org/10.1007/3-211-27377-8_11

Download citation

  • DOI: https://doi.org/10.1007/3-211-27377-8_11

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-20686-7

  • Online ISBN: 978-3-211-27377-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation